Furukawa F, Ikehara S, Good R A, Nakamura T, Inoue S, Tanaka H, Imamura S, Hamashima Y
Department of Dermatology, Faculty of Medicine, Kyoto University, Japan.
Thymus. 1988;12(1):11-26.
Restoration of T-cell functions and changes in autoantibody production were studied in BALB/c nu/nu (nude) mice engrafted with syngeneic (BALB/c) or allogeneic (C57BL/6J) thymuses across major histocompatability barriers. T-cell functions, including mitogen responses and antibody production to sheep red blood cells (SRBC), were restored in nude mice engrafted with either allogeneic or syngeneic thymuses. Alloreactivity was evaluated by analysis of the pattern of skin allograft rejection, generation of alloreactive cytotoxic T-lymphocytes (CTLs), or quantitation of mixed-lymphocyte reaction (MLR). BABL/c nude mice engrafted with thymuses from newborn C57BL/6J mice accepted the skin from either thymus donor-type mice or from host-type mice. By contrast, such thymic chimeras rejected skin grafts from a third-party donor. CTLs from nude mice engrafted with C57BL/6J thymuses were cytotoxic to target cells of the third party but not to target cells of the host-type or of the thymus-type. In the MLR assay, spleen cells of nude mice engrafted with C57BL/6J thymuses responded vigorously to third party cells and only slightly to cells of the thymus-type. Low levels of serum IgG and high titers of IgM antibodies to nuclear antigens (but not dsDNA) or skin basal cells were also found in nude mice. Antibodies to both nuclear antigens and skin basal cells disappeared after transplantation of syngeneic thymuses, but not after transplantation of allogeneic thymuses. By contrast, serum IgG levels were restored to normal in nude mice engrafted with either syngeneic or allogeneic thymuses. These results suggest that either HLA-matched or HLA-mismatched thymus grafts may become a viable treatment for certain patients with T cell deficiencies associated with deficient development or maintenance of thymic structure and/or function.
在跨越主要组织相容性屏障移植了同基因(BALB/c)或异基因(C57BL/6J)胸腺的BALB/c裸鼠中,研究了T细胞功能的恢复和自身抗体产生的变化。在移植了异基因或同基因胸腺的裸鼠中,T细胞功能得以恢复,包括对有丝分裂原的反应以及对绵羊红细胞(SRBC)的抗体产生。通过分析皮肤同种异体移植排斥模式、同种异体反应性细胞毒性T淋巴细胞(CTL)的产生或混合淋巴细胞反应(MLR)的定量来评估同种异体反应性。移植了新生C57BL/6J小鼠胸腺的BABL/c裸鼠接受来自胸腺供体类型小鼠或宿主类型小鼠的皮肤。相比之下,这种胸腺嵌合体排斥来自第三方供体的皮肤移植。移植了C57BL/6J胸腺的裸鼠产生的CTL对第三方靶细胞具有细胞毒性,但对宿主类型或胸腺类型的靶细胞无细胞毒性。在MLR试验中,移植了C57BL/6J胸腺的裸鼠的脾细胞对第三方细胞反应强烈,对胸腺类型的细胞反应微弱。在裸鼠中还发现低水平的血清IgG以及针对核抗原(而非双链DNA)或皮肤基底细胞的高滴度IgM抗体。移植同基因胸腺后,针对核抗原和皮肤基底细胞的抗体均消失,但移植异基因胸腺后则不然。相比之下,移植了同基因或异基因胸腺的裸鼠血清IgG水平恢复正常。这些结果表明,HLA匹配或HLA不匹配的胸腺移植可能成为某些与胸腺结构和/或功能发育或维持缺陷相关的T细胞缺陷患者的可行治疗方法。